Skip to content

ExpressionEdits vs synplogen

ExpressionEdits logo

ExpressionEdits

building biology like nature

25 employees · est. 2021 · Cambridge, United Kingdom

VS
synplogen logo

synplogen

Pioneering advanced DNA synthesis with a decade of innovation in genetic engineering, information science, and robotics for high-throughput results

2 employees · est. 2017

synplogen is the older company (2021 vs 2017); ExpressionEdits is the larger of the two.

Side-by-Side Comparison

ExpressionEdits synplogen
Founded
2021 2017 older
Headquarters
Cambridge, United Kingdom Not tracked yet
Employees
25 larger 2
Industry
AI, Biotechnology Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Seed Not tracked yet
Total Funding
$13.00M $2.58B
Funding Rounds
3 6
Services
Development of enhanced gene therapies, Protein expression optimization, Genetic Syntax Engine for transgene design OGAB Method for DNA Synthesis, DNA Library Construction, Gene Therapy Product Development, Biofoundry Services
Target Customers
Biotech companies, Pharmaceutical companies, Research institutions, Healthcare providers Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Gene Therapy Developers
Taxonomy
Genetic EngineeringSynthetic BiologyProtein ExpressionTransgenic DesignGenetic GrammarSynthetic DNA +6 Advanced DNA SynthesisGenetic EngineeringInformation ScienceRoboticsHigh-throughput DNA SynthesisSynthetic Biology +8
Website
expressionedits.com synplogen.com
ExpressionEdits logo

About ExpressionEdits

ExpressionEdits, founded in 2021, is a promising startup in the AI and Biotechnology industries. Headquartered in the United Kingdom, the company is fundamentally redefining genetic design with its slogan, "building biology like nature." By focusing on the precise application of genetic grammar in...

synplogen logo

About synplogen

Synplogen, founded in 2017, is a rising player in the Biopharma and Biotechnology sectors. Their approach leverages over a decade of advancements in genetic engineering, information science, and robotics, primarily developed by Kobe University and other contributors. This unique integration enables...

Also comparing in this category

Comparing more than these two?

Get ExpressionEdits, synplogen and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ExpressionEdits compare?

A PDF of ExpressionEdits and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ExpressionEdits was founded in 2021, based in Cambridge, United Kingdom, with 25 employees. ExpressionEdits, founded in 2021, is a promising startup in the AI and Biotechnology industries. Headquartered in the United Kingdom, the company is fundamentally redefining genetic design with its sl. synplogen was founded in 2017, with 2 employees. Synplogen, founded in 2017, is a rising player in the Biopharma and Biotechnology sectors. Their approach leverages over a decade of advancements in genetic engineering, information science, and robot.
ExpressionEdits has raised $13.00M and synplogen $2.58B. Latest stage: ExpressionEdits Seed.
Both work in Biotechnology and list genetic engineering and synthetic biology among their focus areas.

Compare ExpressionEdits with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ExpressionEdits on 22 Mar 2026, and synplogen on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout